MAPT and Alzheimer disease: The research framework proposed by NIA-AA in 2018 categorized the biomarkers of AD as A/T(N), where A represents Aβ deposition, T represents tau hyperphosphorylation and neurofibrillary tangle (NFT) formation, and N represents neuronal loss and neurodegeneration (Jack et al., 2018).